Preparation and Characterization of Latent α1-Antitrypsin (*)
暂无分享,去创建一个
D. Lomas | R. Carrell | M. Wardell | P. Elliott | W. Chang | Wun-Shaing W. Chang | R. Carrell | W. Chang
[1] Thomas E. Creighton,et al. Protein structure : a practical approach , 1997 .
[2] R. Carrell,et al. Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp) , 1994, The Journal of clinical investigation.
[3] J. Huntington,et al. Alpha 1-proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways. , 1994, Biochemistry.
[4] J. Potempa,et al. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. , 1994, The Journal of biological chemistry.
[5] B. Cooperman,et al. Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop , 1994, Nature Structural Biology.
[6] W. Hol,et al. The intact and cleaved human antithrombin III complex as a model for serpin–proteinase interactions , 1994, Nature Structural Biology.
[7] P. Liljeström,et al. Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms. , 1993, European journal of biochemistry.
[8] C. Hack,et al. A hinge region mutation in C1-inhibitor (Ala436-->Thr) results in nonsubstrate-like behavior and in polymerization of the molecule. , 1993, The Journal of biological chemistry.
[9] P. Stein,et al. Mobile reactive centre of serpins and the control of thrombosis , 1993, Nature.
[10] D. Lomas,et al. Alpha 1-antitrypsin Siiyama (Ser53-->Phe). Further evidence for intracellular loop-sheet polymerization. , 1993, The Journal of biological chemistry.
[11] M. Delarue,et al. Crystal structure of cleaved bovine antithrombin III at 3.2 A resolution. , 1993, Journal of molecular biology.
[12] D. Lomas,et al. Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin. , 1993, Biochemistry.
[13] W. Poller,et al. The molecular basis of α1-antichymotrypsin deficiency in a heterozygote with liver and lung disease , 1993 .
[14] D. Lomas,et al. The mechanism of Z α1-antitrypsin accumulation in the liver , 1993, Nature.
[15] R. Huber,et al. Crystal structure of cleaved equine leucocyte elastase inhibitor determined at 1.95 A resolution. , 1992, Journal of molecular biology.
[16] R. Carrell,et al. Serpins: mobile conformations in a family of proteinase inhibitors , 1992, Current Biology.
[17] J. Enghild,et al. Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis. , 1992, Biochemistry.
[18] R. Pain,et al. Effects of glycosylation on the folding and stability of human, recombinant and cleaved alpha 1-antitrypsin. , 1992, Journal of molecular biology.
[19] E. Goldsmith,et al. Structural basis of latency in plasminogen activator inhibitor-1 , 1992, Nature.
[20] P. Andreasen,et al. Type‐1 inhibitor of plasminogen activators , 1991, FEBS letters.
[21] P. Stein,et al. Mobile reactive centre of serpins and the control of thrombosis , 1991, Nature.
[22] A G Leslie,et al. Crystal structure of uncleaved ovalbumin at 1.95 A resolution. , 1991, Journal of molecular biology.
[23] J. Travis,et al. Evidence for a tetrahedral intermediate complex during serpin-proteinase interactions. , 1991, The Journal of biological chemistry.
[24] W. R. Wikoff,et al. Substrate properties of C1 inhibitor Ma (alanine 434----glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor/substrate status. , 1991, The Journal of biological chemistry.
[25] R. Huber,et al. Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins. , 1991, Journal of molecular biology.
[26] Robert Huber,et al. Ligand binding: proteinase-protein inhibitor interactions , 1991 .
[27] P. Gaffney,et al. Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor. , 1991, Biochemistry.
[28] D. Lawrence,et al. Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants. , 1990, The Journal of biological chemistry.
[29] R. Huber,et al. Structural transition of α1‐antitrypsin by a peptide sequentially similar to β‐strand s4A , 1990 .
[30] A. Leslie,et al. Crystal structure of ovalbumin as a model for the reactive centre of serpins , 1990, Nature.
[31] T. Grundström,et al. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells. , 1989, European journal of biochemistry.
[32] R. Carrell,et al. Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. , 1989, Biochemistry.
[33] V. Weiss,et al. Plasma serine proteinase inhibitors (serpins) exhibit major conformational changes and a large increase in conformational stability upon cleavage at their reactive sites. , 1988, The Journal of biological chemistry.
[34] K. Okada,et al. Bovine endothelial cell plasminogen activator inhibitor. Purification and heat activation. , 1988, European journal of biochemistry.
[35] P. Gettins,et al. Properties of thrombin- and elastase-modified human antithrombin III. , 1988, Biochemistry.
[36] E. Levin,et al. Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells , 1987 .
[37] A. Aksu,et al. Amino acid epimerization in planktonic foraminifera suggests slow sedimentation rates for Alpha Ridge, Arctic Ocean , 1986, Nature.
[38] D. Loskutoff,et al. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. , 1985, The Journal of biological chemistry.
[39] R. Huber,et al. Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. , 1984, Journal of molecular biology.
[40] J. Travis,et al. [55] Human α1-proteinase inhibitor , 1981 .
[41] I. Kato,et al. Protein inhibitors of proteinases. , 1980, Annual review of biochemistry.
[42] D. Johnson,et al. Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor. , 1978, The Journal of biological chemistry.
[43] A. Simoncsits,et al. Synthesis of pppGpN type dinucleotide derivatives: the 5' end sequence of some RNAs. , 1975, Nucleic acids research.